Insider · CIK 0001728746
James Woodruff Lillie
Files at MPLT (MapLight Therapeutics, Inc.). First filing Apr 17, 2026, latest May 11, 2026.
James Woodruff Lillie files SEC Form 4 as officer at MPLT (MapLight Therapeutics, Inc.). Since Apr 17, 2026, James Woodruff Lillie has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.6M, the latest filed on May 11, 2026.
A track record needs three past buys with six months of prices behind them; James Woodruff Lillie has 0, so none is measured yet.
The newest scored trade: sold $20k of MPLT on May 7, 2026, filed May 11, 2026, scored 10 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $1.6M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MPLT: MapLight Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | MapLight Therapeutics, Inc. | $20k 721 shares | -0% | +128% from low-9% from high | |
| 40Moderate | MapLight Therapeutics, Inc. | $1.5M 51,707 shares | -18% | +123% from low-11% from high | |
| 40Moderate | MapLight Therapeutics, Inc. | $123k 4,513 shares | -2% | +110% from low-9% from high |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -721 | $28.28 | $20k | 242,729 | May 11, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -9,250 | $27.50 | $254k | 285,907 | May 6, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -5,526 | $28.37 | $157k | 280,381 | May 6, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -320 | $29.56 | $9,459 | 280,061 | May 6, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -705 | $30.08 | $21k | 279,356 | May 6, 2026 |
| May 5, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -10,132 | $28.12 | $285k | 269,224 | May 6, 2026 |
| May 5, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -963 | $29.00 | $28k | 268,261 | May 6, 2026 |
| May 6, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -8,390 | $28.04 | $235k | 259,871 | May 6, 2026 |
| May 6, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -16,421 | $29.13 | $478k | 243,450 | May 6, 2026 |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -1,730 | $26.82 | $46k | 297,940 | Apr 17, 2026 |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -686 | $27.01 | $19k | 297,254 | Apr 17, 2026 |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -2,097 | $27.49 | $58k | 295,157 | Apr 17, 2026 |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +7,730 | $0.00 | $0 | 298,862 | Feb 9, 2026 |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +31,395 | $0.00 | $0 | 31,395 | Feb 9, 2026 |
| Jan 27, 2026 | MPLT MapLight Therapeutics, Inc. | FTax withholding Voting Common Stock | -45,055 | $17.98 | $810k | 291,132 | Jan 29, 2026 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +32,539 | $0.00 | $0 | 32,539 | Oct 28, 2025 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +132,023 | $0.00 | $0 | 132,023 | Oct 28, 2025 |
Questions about James Woodruff Lillie
Answered from the filings on this page, as of the latest one.
Is James Woodruff Lillie buying or selling?
In the last 12 months James Woodruff Lillie reported 0 open-market buys worth $0 and 3 open-market sells worth $1.6M on SEC Form 4; the latest was sold $20k of MPLT on May 7, 2026. Grants, option exercises and tax withholding are not counted.
How did James Woodruff Lillie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Woodruff Lillie has 0.
Where does James Woodruff Lillie file Form 4?
James Woodruff Lillie has filed Form 4 at MPLT (MapLight Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.